Mission

“Our global quest is to improve the quality of human life by enabling people to do more, feel better and live longer.”

We at GSK will dedicate ourselves to delivering innovative medicines and products that help millions of people around the world live longer, healthier and happier lives.  For each of  us, this should be a “quest” ---- a daily search for ways that we, as individuals, can contribute our time, our talents, and our ideas to achieve as a company what is a truly noble mission for the benefit of society. 

Our Spirit
“We undertake our quest with the enthusiasm of entrepreneurs, excited by the constant search for innovation. We value performance achieved with integrity. We will attain success as a world class global leader with each and every one of our people contributing with passion and an unmatched sense of urgency.”
Our mission gives us purpose. Our size gives us opportunity. Our spirit gives us the qualities as individuals and as an organization that will enable us to turn our opportunities into achievements.  Our spirit will guide us, keep us focused, and differentiate us from the competition.
Who are we? We are a global team of creative people, intent on always looking for new and better ways to do our jobs.  We will cross borders and boundaries, share with, and learn from one another.  We will focus on performance, but we recognize there is no achievement without integrity.

Strategic Intent
“We want to become the indisputable leader in our industry.”
While we are the leading pharmaceutical company with combined sales of over ₤16 billion, a leading market share of 6.9% and 100,000 employees worldwide, we will become the indisputable leader in terms of how we use that size to achieve our mission, and improve the quality of human life. 


^ Back to top
Philippines

GSK at a glance

We are the only pharmaceutical company to tackle the three "priority" diseases identified by the World Health Organization: HIV/AIDS, tuberculosis and malaria
Our business employs over 100,000 people in 117 countries
We make almost four billion packs of medicines and healthcare products every year
We screen about 65 million compounds every year in our search for new medicines
We supply one quarter of the world's vaccines and by the end of 2007 we had 23 vaccines in clinical development
To date, we have donated over 750 million albendazole tablets to help elimitate lymphatic filariasis (elephantiasis) in the world
In 2006 we shipped 126 million tablets of preferentially-priced Combivir and Epivir (our HIV treatments) to developing countries
Almost 100 countries benefitted from our humanitarian product donations